Drugs / CKD-843
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06916793 | Apr 2025 → Sep 2027 expected | androgenetic alopecia | Chong Kun Dang Pharmaceutical | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-843 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06916793 ↗ |
| Route | Intramuscular | “IM injection every 3 months for 12 months” NCT06916793 ↗ |